CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

被引:2067
作者
Thornton, AM [1 ]
Shevach, EM [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
suppressor T cells; interleukin; 2; autoimmune disease; self-tolerance; interleukin 2 receptor alpha chain (CD25);
D O I
10.1084/jem.188.2.287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peripheral tolerance may be maintained by a population of regulatory/suppressor T cells that prevent the activation of autoreactive T cells recognizing tissue-specific antigens. We have previously shown that CD4(+)CD25(+) T cells represent a unique population of suppressor T cells that can prevent both the initiation of organ-specific autoimmune disease after day 3 thymectomy and the effector function of cloned autoantigen-specific CD4(+) T cells. To analyze the mechanism of action of these cells, we established an in vitro model system that mimics the function of these cells in vivo. Purified CD4(+)CD25(+) cells failed to proliferate after stimulation with interleukin (IL)-2 alone or stimulation through the T cell receptor (TCR). When cocultured With CD4(+)CD25(-) cells, the CD4(+)CD25(+) cells markedly suppressed proliferation by specifically inhibiting the production of TL-2. The inhibition was not cytokine mediated, was dependent on cell contact between the regulatory cells and the responders, and required activation of the suppressors via the TCR. Inhibition could be overcome by the addition to the cultures of IL-2 or anti-CD28, suggesting that the CD4(+)CD25(+) cells may function by blocking the delivery of a costimulatory signal. Induction of CD25 expression on CD25(-) T cells in vitro or in vivo did not result in the generation of suppressor activity. Collectively, these data support the concept that the CD4(+)CD25(+) T cells in normal mice may represent a distinct lineage of "professional" suppressor cells.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 40 条
[1]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[2]  
BONOMO A, 1995, J IMMUNOL, V154, P6602
[3]   Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells [J].
Chen, YH ;
Inobe, J ;
Kuchroo, VK ;
Baron, JL ;
Janeway, CA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :388-391
[4]   Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8 [J].
Cobbold, SP ;
Adams, E ;
Marshall, SE ;
Davies, JD ;
Waldmann, H .
IMMUNOLOGICAL REVIEWS, 1996, 149 :5-33
[5]  
Field EH, 1996, J IMMUNOL, V157, P3796
[6]   EVIDENCE THAT THE T-CELL REPERTOIRE OF NORMAL RATS CONTAINS CELLS WITH THE POTENTIAL TO CAUSE DIABETES - CHARACTERIZATION OF THE CD4+ T-CELL SUBSET THAT INHIBITS THIS AUTOIMMUNE POTENTIAL [J].
FOWELL, D ;
MASON, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :627-636
[7]   A SINGLE MAJOR PATHWAY OF LYMPHOCYTE-T INTERACTIONS IN ANTIGEN-SPECIFIC IMMUNE SUPPRESSION [J].
GERMAIN, RN ;
BENACERRAF, B .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 13 (01) :1-10
[8]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[9]   Molecular role of TGF-beta, secreted from a new type of CD4(+) suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice [J].
Han, HS ;
Jun, HS ;
Utsugi, T ;
Yoon, JW .
JOURNAL OF AUTOIMMUNITY, 1997, 10 (03) :299-307
[10]   GENETIC SUSCEPTIBILITY TO POST-THYMECTOMY AUTOIMMUNE-DISEASES IN MICE [J].
KOJIMA, A ;
PREHN, RT .
IMMUNOGENETICS, 1981, 14 (1-2) :15-27